↓ Skip to main content
What is this page? Embed badge

[177Lu]Lu-PSMA-617 in patients with PSMA-positive metastatic androgen pathway modulator-naive/sensitive prostate cancer (PSMAddition): a phase 3 randomised, controlled trial

Overview of attention for article published in The Lancet, August 2026
Altmetric Badge

About this Attention Score

  • In the top 5% of all research outputs scored by Altmetric
  • High Attention Score compared to outputs of the same age (99th percentile)
  • High Attention Score compared to outputs of the same age and source (91st percentile)

Mentioned by

news
12 news outlets
blogs
2 blogs
twitter
33 X users
bluesky
2 Bluesky users

Readers on

mendeley
4 Mendeley
So far, Altmetric has seen 16 news stories from 12 outlets.
On.ge

გარღვევამ, შესაძლოა, მეტასტაზური პროსტატის კიბოს მკურნალობა შეცვალოს

On.ge,

მე-3 ფაზის კლინიკური კვლევის თანახმად, რომელსაც უაილ კორნელის მედიცინის ინსტიტუტი (Weill Cornell Medicine), ნიუ-იორკ-პრესბიტერიან…

This page shows the most recent news stories that mention this research output. Click here to find out how to access more activity, including 12 additional news stories.